BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 25918992)

  • 1. Neuropsychological and functional outcomes in recent-onset major depression, bipolar disorder and schizophrenia-spectrum disorders: a longitudinal cohort study.
    Lee RS; Hermens DF; Naismith SL; Lagopoulos J; Jones A; Scott J; Chitty KM; White D; Robillard R; Scott EM; Hickie IB
    Transl Psychiatry; 2015 Apr; 5(4):e555. PubMed ID: 25918992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
    Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia.
    Malhi GS; Ivanovski B; Hadzi-Pavlovic D; Mitchell PB; Vieta E; Sachdev P
    Bipolar Disord; 2007; 9(1-2):114-25. PubMed ID: 17391355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct and shared contributions of diagnosis and symptom domains to cognitive performance in severe mental illness in the Paisa population: a case-control study.
    Service SK; Vargas Upegui C; Castaño Ramírez M; Port AM; Moore TM; Munoz Umanes M; Agudelo Arango LG; Díaz-Zuluaga AM; Melo Espejo J; López MC; Palacio JD; Ruiz Sánchez S; Valencia J; Teshiba TM; Espinoza A; Olde Loohuis L; De la Hoz Gomez J; Brodey BB; Sabatti C; Escobar JI; Reus VI; Lopez Jaramillo C; Gur RC; Bearden CE; Freimer NB
    Lancet Psychiatry; 2020 May; 7(5):411-419. PubMed ID: 32353276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability and course of neuropsychological deficits in manic and depressed bipolar patients compared to patients with Major Depression.
    Gruber S; Rathgeber K; Bräunig P; Gauggel S
    J Affect Disord; 2007 Dec; 104(1-3):61-71. PubMed ID: 17360041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological and socio-occupational functioning in young psychiatric outpatients: a longitudinal investigation.
    Lee RS; Hermens DF; Redoblado-Hodge MA; Naismith SL; Porter MA; Kaur M; White D; Scott EM; Hickie IB
    PLoS One; 2013; 8(3):e58176. PubMed ID: 23469268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deconstructing Bipolar Disorder and Schizophrenia: A cross-diagnostic cluster analysis of cognitive phenotypes.
    Lee J; Rizzo S; Altshuler L; Glahn DC; Miklowitz DJ; Sugar CA; Wynn JK; Green MF
    J Affect Disord; 2017 Feb; 209():71-79. PubMed ID: 27888723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders: a prospective 1 year follow-up study.
    Martino DJ; Marengo E; Igoa A; Scápola M; Ais ED; Perinot L; Strejilevich SA
    J Affect Disord; 2009 Jul; 116(1-2):37-42. PubMed ID: 19033081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive Heterogeneity across Schizophrenia and Bipolar Disorder: A Cluster Analysis of Intellectual Trajectories.
    Vaskinn A; Haatveit B; Melle I; Andreassen OA; Ueland T; Sundet K
    J Int Neuropsychol Soc; 2020 Oct; 26(9):860-872. PubMed ID: 32423506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tobacco smoking on neuropsychological function in schizophrenia in comparison to other psychiatric disorders and non-psychiatric controls.
    Morisano D; Wing VC; Sacco KA; Arenovich T; George TP
    Am J Addict; 2013 Jan; 22(1):46-53. PubMed ID: 23398226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological performance of patients with soft bipolar spectrum disorders.
    Lin K; Xu G; Lu W; Ouyang H; Dang Y; Guo Y; So KF; Lee TM
    Bipolar Disord; 2015 Mar; 17(2):194-204. PubMed ID: 25048414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-year outcomes in first admission adolescent inpatients: clinical and cognitive characteristics at admission as predictors.
    Pogge DL; Insalaco B; Bertisch H; Bilginer L; Stokes J; Cornblatt BA; Harvey PD
    Psychiatry Res; 2008 Jul; 160(1):47-54. PubMed ID: 18534688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses.
    Bombin I; Mayoral M; Castro-Fornieles J; Gonzalez-Pinto A; de la Serna E; Rapado-Castro M; Barbeito S; Parellada M; Baeza I; Graell M; Payá B; Arango C
    Psychol Med; 2013 Apr; 43(4):757-68. PubMed ID: 22831788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in neurocognitive functioning during transition to manifest disease: comparison of individuals at risk for schizophrenic and bipolar affective psychoses.
    Metzler S; Dvorsky D; Wyss C; Müller M; Gerstenberg M; Traber-Walker N; Walitza S; Theodoridou A; Rössler W; Heekeren K
    Psychol Med; 2015 Jul; 45(10):2123-34. PubMed ID: 25640248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder.
    Bowie CR; Depp C; McGrath JA; Wolyniec P; Mausbach BT; Thornquist MH; Luke J; Patterson TL; Harvey PD; Pulver AE
    Am J Psychiatry; 2010 Sep; 167(9):1116-24. PubMed ID: 20478878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.